Jundishapur Journal of Microbiology

Published by: Kowsar

Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia

Mustafa Gokhan Gozel 1 , * , Cem Celik 2 and Nazif Elaldi 1
Authors Information
1 Department of Infectious Diseases and Clinical Microbiology, Cumhuriyet University Education and Research Hospital, Sivas, Turkey
2 Department of Medical Microbiology, Cumhuriyet University Education and Research Hospital, Sivas, Turkey
Article information
  • Jundishapur Journal of Microbiology: August 01, 2015, 8 (8); e23569
  • Published Online: August 22, 2015
  • Article Type: Research Article
  • Received: September 12, 2014
  • Accepted: January 6, 2015
  • DOI: 10.5812/jjm.23569

To Cite: Gokhan Gozel M, Celik C, Elaldi N. Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia, Jundishapur J Microbiol. 2015 ; 8(8):e23569. doi: 10.5812/jjm.23569.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Tan CK, Liaw SJ, Yu CJ, Teng LJ, Hsueh PR. Extensively drug-resistant Stenotrophomonas maltophilia in a tertiary care hospital in Taiwan: microbiologic characteristics, clinical features, and outcomes. Diagn Microbiol Infect Dis. 2008; 60(2): 205-10[DOI][PubMed]
  • 2. Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008; 70(2): 101-8[DOI][PubMed]
  • 3. Samonis G, Karageorgopoulos DE, Maraki S, Levis P, Dimopoulou D, Spernovasilis NA, et al. Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One. 2012; 7(5)[DOI][PubMed]
  • 4. Tseng CC, Fang WF, Huang KT, Chang PW, Tu ML, Shiang YP, et al. Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia. Infect Control Hosp Epidemiol. 2009; 30(12): 1193-202[DOI][PubMed]
  • 5. Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004; 37(6): 359-65[PubMed]
  • 6. Chung HS, Hong SG, Lee Y, Kim M, Yong D, Jeong SH, et al. Antimicrobial susceptibility of Stenotrophomonas maltophilia isolates from a Korean tertiary care hospital. Yonsei Med J. 2012; 53(2): 439-41[DOI][PubMed]
  • 7. Morata L, Cobos-Trigueros N, Martinez JA, Soriano A, Almela M, Marco F, et al. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother. 2012; 56(9): 4833-7[DOI][PubMed]
  • 8. Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002; 34(12): 1653-6[DOI][PubMed]
  • 9. Park YS, Kim SY, Park SY, Kang JH, Lee HS, Seo YH, et al. Pseudooutbreak of Stenotrophomonas maltophilia bacteremia in a general ward. Am J Infect Control. 2008; 36(1): 29-32[DOI][PubMed]
  • 10. Safdar A, Rolston KV. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis. 2007; 45(12): 1602-9[DOI][PubMed]
  • 11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988; 16(3): 128-40[DOI]
  • 12. Clinical and Laboratory Standards Institute . performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. 2008;
  • 13. Hanes SD, Demirkan K, Tolley E, Boucher BA, Croce MA, Wood GC, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis. 2002; 35(3): 228-35[DOI][PubMed]
  • 14. Maningo E, Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect. 1995; 31(2): 89-92[PubMed]
  • 15. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad ,I, Safdar A. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004. Eur J Clin Microbiol Infect Dis. 2007; 26(1): 13-20[DOI][PubMed]
  • 16. Muder RR, Harris AP, Muller S, Edmond M, Chow JW, Papadakis K, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin Infect Dis. 1996; 22(3): 508-12[PubMed]
  • 17. Cherif H, Kronvall G, Bjorkholm M, Kalin M. Bacteraemia in hospitalised patients with malignant blood disorders: a retrospective study of causative agents and their resistance profiles during a 14-year period without antibacterial prophylaxis. Hematol J. 2003; 4(6): 420-6[DOI][PubMed]
  • 18. Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, et al. Stenotrophomonas maltophilia bloodstream infection: comparison between community-onset and hospital-acquired infections. J Microbiol Immunol Infect. 2014; 47(1): 28-35[DOI][PubMed]
  • 19. Falagas ME, Kastoris AC, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Dimopoulos G. Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol. 2009; 4(9): 1103-9[DOI][PubMed]
  • 20. Araoka H, Baba M, Yoneyama A. Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996-2009. Eur J Clin Microbiol Infect Dis. 2010; 29(5): 605-8[DOI][PubMed]
  • 21. Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004; 37(6): 350-8[PubMed]
  • 22. Boktour M, Hanna H, Ansari S, Bahna B, Hachem R, Tarrand J, et al. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer. 2006; 106(9): 1967-73[DOI][PubMed]
  • 23. Guyot A, Turton JF, Garner D. Outbreak of Stenotrophomonas maltophilia on an intensive care unit. J Hosp Infect. 2013; 85(4): 303-7[DOI][PubMed]
  • 24. Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, et al. Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case-control study. Infect Control Hosp Epidemiol. 2003; 24(4): 269-74[DOI][PubMed]
  • 25. Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012; 25(1): 2-41[DOI][PubMed]
  • 26. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect Dis. 2009; 9(5): 312-23[DOI][PubMed]
  • 27. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control. 2007; 35(9): 606-12[DOI][PubMed]
  • 28. Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010; 23(4): 320-6[PubMed]
  • 29. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol. 2007; 28(7): 825-31[DOI][PubMed]
  • 30. Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur J Clin Microbiol Infect Dis. 2008; 27(10): 901-6[DOI][PubMed]
  • 31. Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, et al. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy. Transpl Infect Dis. 2012; 14(4): 355-63[DOI][PubMed]
  • 32. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis. 2010; 51 Suppl 1-7[DOI][PubMed]
  • 33. Korvick JA, Bryan CS, Farber B, Beam TJ, Schenfeld L, Muder RR, et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother. 1992; 36(12): 2639-44[PubMed]
  • 34. Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis. 2000; 31(3): 705-11[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments